The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Short-term pre-operative durvalumab (MEDI 4736) in early small triple-negative breast cancer patients (POP-Durva).
 
Joana Ribeiro
Honoraria - Gilead Sciences; Lilly
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo
Research Funding - AstraZeneca Canada
Travel, Accommodations, Expenses - Lilly; Novartis
 
Julia Dixon-Douglas
Honoraria - Gilead Lide
 
Isabelle Pic
No Relationships to Disclose
 
Quentin Blampey
No Relationships to Disclose
 
Elie Rassy
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; Novartis; Seagen
Research Funding - Gilead Sciences; Menarini; MSD
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Menarini; Mundipharma; Novartis; Pfizer; Roche
 
Nusaibah Ibrahimi
No Relationships to Disclose
 
Marie-Ange Mouret-Reynier
No Relationships to Disclose
 
Monica Arnedos
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sandoz-Novartis; Stemline Therapeutics; Veracyte
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Kamar Serhal
No Relationships to Disclose
 
Alessandro Viansone
Honoraria - Seagen
Consulting or Advisory Role - Seagen
Speakers' Bureau - AstraZeneca/Daiichi Sankyo
Research Funding - Pfizer
Expert Testimony - Seagen
Travel, Accommodations, Expenses - Eisai Europe
 
Fernando Bazan
No Relationships to Disclose
 
Salim Laghouati
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; Olema Oncology (Inst); PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Magali Lacroix-Triki
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; MSD Oncology; Myriad Genetics; Roche Diagnostics Solutions
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Exact Sciences
 
Corinne Balleyguier
Travel, Accommodations, Expenses - Bracco Diagnostics; GE Healthcare; Guerbet; Siemens Healthineers
 
Maud Kamal
No Relationships to Disclose
 
Nadege Bercovici
No Relationships to Disclose
 
Paul-Henri Cournede
No Relationships to Disclose
 
Fabrice Andre
Consulting or Advisory Role - AstraZeneca (Inst); Boston Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Lilly; Lilly (Inst); N-Power Medicine (Inst); Novartis (Inst); Owkin (Inst); Pfizer (Inst); ROCHE (Inst); SERVIER (Inst)
Research Funding - AstraZeneca (Inst); Daiichi (Inst); Guardant Health (Inst); Lilly (Inst); Novartis (Inst); Owkin (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche